Using PGC-1α, invasive cancers enhance mitochondrial biogenesis resulting in increased OXPHOS [29, 30], while silencing of PGC-1α decreases tumor growth and its invasive potential [30]. The gene discussed is PPARGC1A; the disease is cancer.